Skip to main content
. 2019 Jul 24;2019(7):CD012412. doi: 10.1002/14651858.CD012412.pub3

Mihatsch 2002.

Study characteristics
Methods RCT
Participants Very low birth weight (< 1500 g) infants
Interventions Empirical use of extensively hydrolysed (whey‐casein) preterm formula* (n = 41)
Standard preterm formula* (n = 46)
Outcomes Necrotising enterocolitis
Proportion of enteral feeds with gastric residual volumes > 5 mL/kg birth weight
Notes Division of Neonatology and Pediatric Critical Care, Department of Pediatrics, Ulm University, 89070 Ulm, Germany
Trial dates: 1999 to 2001
* Energy content of both formulas: 80 kcal/100 mL
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer generated
Allocation concealment (selection bias) Unclear risk Sealed envelopes ‐ unclear whether opaque
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk "Double‐blind"; same appearance, but investigators acknowledged different tastes
Blinding of outcome assessment (detection bias)
All outcomes Unclear risk "Double‐blind"
Incomplete outcome data (attrition bias)
All outcomes High risk 129 infants recruited initially, then 42 excluded post hoc because they received > 10% of enteral intake as human milk
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funder: Milupa GmbH, Germany (manufacturer of the trial formula)